Ireland - English - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - ibuprofen - oral suspension - 100 mg/5ml - propionic acid derivatives

Malta - English - Medicines Authority

pinewood laboratories limited ballymacarbry, clonmel, co. tipperary, ireland - methadone hydrochloride - oral solution - methadone hydrochloride 1 mg/ml - other nervous system drugs

United States - English - NLM (National Library of Medicine)

par pharmaceutical - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam 100 mg in 1 ml - levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution, usp is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. none. levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.9) ]. pregnancy category c there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam should be used during pregnancy only if the potential benefit just

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam oral solution  is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam oral solution  is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution  is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. levetiracetam is contraindicated in patients with a hypersensitivity to levetiracetam. reactions have included anaphylaxis and angioedema [see warnings and precautions (5.4)] . levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.10)] . teratogenic effects pregnancy category c   there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of dev

United States - English - NLM (National Library of Medicine)

cardinal health - levetiracetam (unii: 44yrr34555) (levetiracetam - unii:44yrr34555) - levetiracetam oral solution usp is indicated as adjunctive therapy in the treatment of partial onset seizures in adults and children 1 month of age and older with epilepsy. levetiracetam oral solution usp is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents 12 years of age and older with juvenile myoclonic epilepsy. levetiracetam oral solution usp is indicated as adjunctive therapy in the treatment of primary generalized tonic-clonic seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy. none. levetiracetam blood levels may decrease during pregnancy [see warnings and precautions (5.9) ]. pregnancy category c there are no adequate and controlled studies in pregnant women. in animal studies, levetiracetam produced evidence of developmental toxicity, including teratogenic effects, at doses similar to or greater than human therapeutic doses. levetiracetam should be used during pregnancy only if the potential benefit justifies t

New Zealand - English - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - nicotine tartrate 3.072mg equivalent to nicotine base 1.0 mg - lozenge - 1 mg - active: nicotine tartrate 3.072mg equivalent to nicotine base 1.0 mg excipient: aspartame colloidal silicon dioxide levomenthol magnesium stearate maltitol peppermint oil polyacrylate dispersion 30% purified water sodium bicarbonate sodium carbonate xanthan gum - for the relief of nicotine withdrawal symptoms, in nicotine dependency as an aid to smoking cessation. may be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping completely. may be used by smokers who are unable or not ready to quit on occasions when they want to temporarily abstain from smoking.

New Zealand - English - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - nicotine tartrate 6.144mg equivalent to nicotine base 2.0 mg - lozenge - 2 mg - active: nicotine tartrate 6.144mg equivalent to nicotine base 2.0 mg excipient: aspartame colloidal silicon dioxide levomenthol magnesium stearate maltitol peppermint oil polyacrylate dispersion 30% purified water sodium bicarbonate sodium carbonate xanthan gum - for the relief of nicotine withdrawal symptoms, in nicotine dependency as an aid to smoking cessation. may be used as part of a smoking reduction strategy by smokers who are unable or not ready to stop smoking abruptly as a step towards stopping completely. may be used by smokers who are unable or not ready to quit on occasions when they want to temporarily abstain from smoking.

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - ibuprofen 2%;   - oral suspension - 100 mg/5ml - active: ibuprofen 2%   excipient: citric acid monohydrate dispersible cellulose maltitol orange flavour 4051 orange flavour sweet no.1 polysorbate 80 purified water saccharin sodium sodium benzoate sodium citrate dihydrate sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate xanthan gum - temporary relief of fever, discomfort and pain associated with teething, toothache, headache, earache, sore throat, immunization, cold and flu symptoms and muscular aches and pain (label claim)

New Zealand - English - Medsafe (Medicines Safety Authority)

multichem nz limited - ibuprofen 2% - oral suspension - 100 mg/5ml - active: ibuprofen 2% excipient: citric acid monohydrate dispersible cellulose maltitol orange flavour 4051 orange flavour sweet no.1 polysorbate 80 purified water saccharin sodium sodium benzoate sodium citrate dihydrate sodium methyl hydroxybenzoate sodium propyl hydroxybenzoate xanthan gum - temporary relief of pain and fever

New Zealand - English - Medsafe (Medicines Safety Authority)

viatris limited - lamivudine 150mg; zidovudine 300mg - film coated tablet - active: lamivudine 150mg zidovudine 300mg excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose opadry white propylene glycol purified water sodium starch glycolate - indicated for the treatment of hiv infected adults and adolescents over the age of 12 years, with progressive immunodeficiency (cd4+ count = < 500 cells/mm³).